Skip to main content
PMC home page
Cell Death and Differentiation logoLink to Cell Death and Differentiation
. 2014 Apr 25;21(8):1229–1239. doi: 10.1038/cdd.2014.40

Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis

J Xu 1,2, Y Jiang 2,*, J Wang 1,2, X Shi 1,3, Q Liu 4,5, Z Liu 1,2, Y Li 1, M J Scott 1, G Xiao 6, S Li 7, L Fan 8, T R Billiar 1,9, M A Wilson 1,10, J Fan 1,9,10,*
PMCID: PMC4085529  PMID: 24769733

Abstract

Macrophages can be activated and regulated by high-mobility group box 1 (HMGB1), a highly conserved nuclear protein. Inflammatory functions of HMGB1 are mediated by binding to cell surface receptors, including the receptor for advanced glycation end products (RAGE), Toll-like receptor (TLR)2, TLR4, and TLR9. Pyroptosis is a caspase-1-dependent programmed cell death, which features rapid plasma membrane rupture, DNA fragmentation, and release of proinflammatory intracellular contents. Pyroptosis can be triggered by various stimuli, however, the mechanism underlying pyroptosis remains unclear. In this study, we identify a novel pathway of HMGB1-induced macrophage pyroptosis. We demonstrate that HMGB1, acting through RAGE and dynamin-dependent signaling, initiates HMGB1endocytosis, which in turn induces cell pyroptosis. The endocytosis of HMGB1 triggers a cascade of molecular events, including cathepsin B release from ruptured lysosomes followed by pyroptosome formation and caspase-1 activation. We further confirm that HMGB1-induced macrophage pyroptosis also occurs in vivo during endotoxemia, suggesting a pathophysiological significance for this form of pyroptosis in the development of inflammation. These findings shed light on the regulatory role of ligand-receptor internalization in directing cell fate, which may have an important role in the progress of inflammation following infection and injury.

Infection and injury, the most challenging factors to the survival of species throughout evolution, are still major causes of human death worldwide. Infection and severe trauma share many overlapping features in the mechanism of activation of the innate immune system through pathogen-associated molecular pattern molecules derived from microbes and damage-associated molecular pattern (DAMP) molecules released by damaged tissues.1, 2 High-mobility group box 1 (HMGB1), a highly conserved ubiquitous protein present in the nucleus and cytoplasm of nearly all cell types, is the prototypic DAMP molecule.3 During infection and sterile tissue injury, HMGB1 is released from cells and serves as a necessary and sufficient mediator of inflammation to induce a variety of cellular responses including cell chemotaxis and release of pro-inflammatory cytokines.4, 5 Inflammatory functions of HMGB1 are mediated by binding to the cell surface receptors, including the receptor for advanced glycation end products (RAGEs), Toll-like receptor (TLR)2, TLR4, and TLR9.6, 7

RAGE is a type I transmembrane protein and a member of the immunoglobulin superfamily expressed in many cell populations, including endothelial cells, vascular smooth muscle cells, neurons, neutrophils, and macrophages/monocytes.8 RAGE has been implicated as a receptor mediating the chemotaxis and cytokine activity of HMGB1 in macrophages and tumor cells.7, 9, 10 RAGE engagement by multiple ligands is linked to a range of signaling pathways including activation of NF-κB,11, 12 PI3K/Akt,13 MAPKs,14, 15 Jak/STAT,16 and Rho GTPases,17 although how RAGE transduces the signaling is not fully addressed.

Pyroptosis is a caspase-1-dependent programmed cell death, which is morphologically and mechanistically distinct from other forms of cell death such as apoptosis and necrosis.18 Previous observations suggested that pyroptosis features rapid plasma membrane rupture and release of proinflammatory intracellular contents, contrasting with the characteristic of apoptosis, which packs cellular contents and induces non-inflammatory phagocytic uptake of the apoptotic bodies by macrophages.19 Pyroptosis can be triggered by various pathological stimuli, such as microbial infection, stroke, heart attack, or cancer;18 however, the mechanism that underlies pyroptosis formation in response to inflammatory mediators remains unclear. In this study, we identify a novel pathway of HMGB1-induced pyroptosis. We demonstrate that HMGB1 acting through RAGE on macrophages triggers dynamin-dependent endocytosis of HMGB1, which in turn induces cell pyroptosis. The endocytosis of HMGB1 initiates a cascade of molecular events, including cathepsin B (CatB) activation and release from ruptured lysosomes, followed by pyroptosome formation and caspase-1 activation. We further confirm that this in vitro observation of HMGB1-induced macrophage pyroptosis also occurs in vivo during endotoxemia, suggesting a pathophysiological significance for pyroptosis in the development of inflammation.

Results

Macrophage endocytosis of HMGB1 is a RAGE-mediated event

HMGB1 as an endogenous DAMP molecule is critically involved in the development of inflammation both at sites of infection and at sterile tissue injury. The precise mechanism of HMGB1 regulation of cellular immune responses remains unclear. In our study defining how HMGB1 signals to produce macrophage responses, we observed rapid endocytosis of HMGB1 in macrophages. As shown in Figure 1a, treatment of mouse alveolar macrophages (AMs) with HMGB1-enhanced green fluorescent protein (EGFP; 100 nmol/l) induced HMGB1-EGFP internalization that occurred in as soon as 5 min after the treatment. This HMGB1-EGFP internalization was specific phagocytosis via HMGB1 in the AMs as EGFP alone was not internalized. The dose-response results are shown in Figure 1b. An apparent HMGB1-EGFP endocytosis can be seen at a concentration of 50 nmol/l. To further define whether HMGB1-EGFP internalization is a specific receptor-dependent event, we isolated bone marrow-derived macrophages (BMMs) from TLR2−/−, TLR4−/−, and RAGE−/− mice and then treated the cells with HMGB1-EGFP (100 nmol/l). The results showed that RAGE deficiency prevented HMGB1 internalization, whereas genetic deletion of TLR2 or TLR4 failed to block HMGB1 internalization (Figures 1c and d), indicating that HMGB1 internalization is RAGE depends. To further determine the pathway of HMGB1 internalization, we treated BMMs with HMGB1-EGFP and Alexa fluor 568-labeled transferrin, a protein that is typically endocytosed through clathrin-dependent pathways, or Alexa fluor 568-labeled cholera toxin (CT)-B, a tracker of lipid raft-dependent pathways. As demonstrated in Figure 1e, internalized HMGB1 did not co-localize with transferrin and CT-B, suggesting that HMGB1 internalization is not mediated through clathrin- or lipid raft-dependent pathways. In contrast, we observed that treatment of the cells with dynamin inhibitor dynasore (30 μg/ml in 0.3% DMSO, Sigma-Aldrich, St. Louis, MO, USA) effectively blocked HMGB1 internalization as shown in Figures 1d and f. The dynasore solvent DMSO alone did not suppress HMGB1 endocytosis (Figure 1f). In order to address if the HMGB1 endocytosis is possibly mediated by contaminated lipopolysaccharide (LPS), HMGB1-EGFP was heated at 100 °C for 5 min before adding to the BMMs. As shown in Figure 1f, heated HMGB1-EGFP failed to induce its endocytosis. Taken together, HMGB1 acting through RAGE initiates its endocytosis into macrophages via a dynamin-dependent pathway.

Figure 1.

Figure 1

Open in a new tab

Macrophage endocytosis of HMGB1 is mediated by RAGE-dependent pathway. (a) Confocal microscopy of alveolar macrophages (AMs) that were isolated from C57BL/6 (wild type, WT) mice and incubated with recombinant protein HMGB1-EGFP (100 nmol/l) or EGFP for 0–30 min. Original magnification × 600; results are representative of three independent experiments. (b) Confocal microscopy of AMs that were isolated from WT mice and incubated with 0–100 nmol/l HMGB1-EGFP for 30 min. Original magnification × 600; results are representative of three independent experiments. (c) Confocal microscopy of AMs that were isolated from WT, TLR2−/−, TLR4−/−, or RAGE−/− mice and incubated with HMGB1-EGFP (100 nmol/l) for 30 min. Original magnification × 600; results are representative of three independent experiments. (d) Changes in average number of intracellular EGFP-tagged protein particles in AMs, which were calculated using confocal microscopy program. The AMs were isolated from WT, TLR2−/−, TLR4−/−, or RAGE−/− mice and incubated with HMGB1-EGFP (100 nmol/l) for 30 min. In some experiments, WT AMs were incubated with HMGB1-EGFP and dynamin inhibitor dynasore (30 μg/ml) for 30 min. The graph shows the mean and S.D., n=9. *P<0.05 versus the group treated with EGFP alone. (e) Confocal microscopy of AMs that were isolated from WT mice and incubated with HMGB1-EGFP and Alexa fluor 568-labeled transferrin, a protein that is typically endocytosed through clathrin-dependent pathways, or Alexa fluor 568-labeled cholera toxin (CT)-B, a tracker of lipid raft-dependent pathways. Original magnification × 600; results are representative of three independent experiments. (f) Confocal microscopy of WT AMs that were incubated with HMGB1-EGFP in the presence or absence of dynasore (30 μg/ml) or DMSO (0.3%) for 30 min. WT AMs were also treated with heated HMGB1-EGFP (100 °C, 5 min) for 30 min. Original magnification × 600; results are representative of three independent experiments

Localization of HMGB1 in lysosomes induces lysosomal destabilization and CatB activation

To track the translocation of endocytosed HMGB1-EGFP in the macrophages, we visualized endosomes and lysosomes with Alexa Fluor 555-tagged anti-early endosome antigen antibody, an endosome detector and LysoTracker probe (Molecular Probes, Eugene, OR, USA), a lysosome detector. We observed that HMGB1 localized in endosomes starting at 15 min after HMGB1 treatment (Figure 2a), followed by translocation into lysosomes at 3 h, and it remained there for at least 9 h (Figure 2b). We then applied fluorescence-tagged DQ ovalbumin to monitor the integrity of the endo-lysosome compartments in the macrophages after HMGB1 endocytosis. The fluorescence of the fluorophore BODIPY-FL (8-chloromethyl-4,4-difluoro-1,3,5,7-tetramethyl-4-bora-3a,4a-diaza-s-indacene) on DQ ovalbumin is normally quenched unless the protein is proteolytically processed into peptides in endo-lysosomal compartments.20 As shown in Figure 2c, in untreated cells (time=0 h), processed DQ ovalbumin was localized to small vesicular and tubular endosomes or lysosomes, as expected. However, notably, there were large swollen lysosomes in more than 85% of macrophages starting from 6 h after HMGB1 treatment. The cells demonstrated a cytosolic pattern of fluorescently processed DQ ovalbumin, which suggested lysosomal rupture or leakage of lysosomal contents into the cytosol21, 22 of HMGB1-treated macrophages (Figure 2c).

Figure 2.

Figure 2

Open in a new tab

Localization of HMGB1 in lysosome induces lysosomal destabilization and cathepsin B (CatB) activation. (a) WT AMs were treated with HMGB1-EGFP (green, 100 nmol/l) for 5 min, 15 min, 30 min, 1 h, 3 h, or 6 h, then immunofluorescence of early endosome antigen 1 (red) were detected. Original magnification × 600; results are representative of three independent experiments. (b) AMs were incubated with both HMGB1-EGFP (green, 100 nmol/l) and LysoTracker Red lysosome dye (red) for 5 min, 30 min, 1 h, 3 h, 6 h, or 12 h. Co-localization of HMGB1 and lysosome was detected using confocal microscopy. Original magnification × 600; results are representative of three independent experiments. (c) AMs were treated with HMGB1 (50 nmol/l) for 0–12 h followed by incubation with DQ ovalbumin (red) for 1 h to visualize lysosome integrity using confocal microscopy. Original magnification × 600; results are representative of three independent experiments. (d) AMs isolated from C57BL/6 (WT) or RAGE−/− mice were incubated with HMGB1 (50 nmol/l) for 30 min in the absence or presence of dynasore (30 μg/ml) or DMSO (0.3%). The cells were then stained with Magic Red CatB detection reagent (red) to visualize activated CatB under confocal microscopy. Original magnification × 600; results are representative of three independent experiments. The insets show higher magnification views. (e–g) Macrophages were stained by Magic Red CatB detection reagent to detect the activation of CatB. The mean fluorescence intensity (MFI) of activated CatB was detected and analyzed using confocal microscopy and OLYMPUS Fluoview Ver.1.7c system. (e) WT AMs were stimulated with HMGB1 (50 nmol/l) for 0–12 h (mean and S.D., n=5. *P<0.05 versus the group of 0 h; **P<0.01 versus the group of 0 h). (f) AMs isolated from WT or RAGE−/− mice were stimulated with HMGB1 (50 nmol/l) for 12 h (mean and S.D., n=9. *P<0.05 versus the other groups). (g) WT AMs were stimulated with HMGB1 (50 nmol/l) for 12 h in the absence or presence of dynasore or DMSO (mean and S.D., n=9. *P<0.05 versus the group labeled with no asterisk)

Lysosomes contain a plethora of proteolytic enzymes including the cathepsin family.23 Activation and release of CatB from lysosomes have been reported as an important mechanism of NLRP3 inflammasome activation following silica crystal uptake.20 To address whether the observed lysosome rupture leads to CatB activation, we measured CatB activity in the cytosol using Magic Red CatB detection reagent. In wild-type (WT) macrophages, a cytosolic pattern of activated CatB staining was observed at 12 h after HMGB1 treatment (Figure 2d). The densitometry analysis showed that cytosolic CatB activity started to increase at 9 h after HMGB1 treatment and reached a 3.5-fold increase at 12 h, as shown in Figure 2e. In contrast, HMGB1 failed to induce CatB activation in RAGE knockout macrophages (Figures 2d and f) as well as WT macrophages pretreated with dynasore (Figure 2g). No effect from dynasore solvent DMSO was found in the experiments as shown in Figures 2d and g. Collectively, these results show that endocytosis of HMGB1 leads to active swelling of lysosomes followed by lysosome destabilization and rupture, therefore resulting in the activation and release of CatB into the cytosolic compartment.

HMGB1 endocytosis results in Nlrp3 inflammasome-independent caspase-1 activation

To determine whether CatB activation and release into the cytosol leads to caspase-1 activation, we investigated caspase-1 cleavage in the BMMs that were treated with HMGB1 for up to 12 h. Caspase-1 cleavage was apparent between 3 and 12 h after HMGB1 treatment (Figure 3a). Noteworthy, HMGB1-induced caspase-1 cleavage at 12 h after HMGB1 treatment was prevented by dynamin inhibition (Figure 3b) or RAGE deletion (Figure 3c), both of which block HMGB1 endocytosis. Furthermore, inhibition of CatB activation, a downstream event after HMGB1 endocytosis, by pre-treating WT BMMs with CatB inhibitor CA074me (Sigma-Aldrich) markedly prevented HMGB1-induced caspase-1 cleavage at 12 h as shown in Figure 3b. The data indicate that HMGB1 acting through separate pathways induces early (3 h) and late (12 h) caspase-1 activation, respectively, and HMGB1 endocytosis is responsible for the late-phase activation of caspase-1.

Figure 3.

Figure 3

Open in a new tab

CatB activation results in Nlrp3-independent caspase-1 activation. (a–e) Immunoblot analysis of activation of caspase-1 in cell lysate of mouse BMMs. (a) WT BMMs were stimulated with HMGB1 (50 nmol/l) for 0–12 h. (b) WT BMMs were stimulated with HMGB1 in the presence or absence of dynasore or CA-074-me (10 μmol/l) for 3 and 12 h, respectively. (c and d) BMMs isolated from WT, Nlrp3−/−, or RAGE−/− mice were stimulated with HMGB1 for 3 or 12 h, respectively. (e) BMMs isolated from WT mice or Nlrp3−/− mice were either stimulated with HMGB1 for 3 h or challenged with LPS for 3 h followed by incubation with ATP for 1 h. Images are representative of three independent experiments

Nlrp3 inflammasomes have been reported as major machinery involved in caspase-1 activation in macrophages.24, 25 To determine the role of Nlrp3 inflammasome in HMGB1-induced caspase-1 activation, we isolated BMMs from Nlrp3−/− mice and treated the cells with HMGB1 for 3 and 12 h. The genetic deletion of Nlrp3 prevented HMGB1-induced caspase-1 cleavage at the early phase (3 h) but had no effect on the caspase-1 cleavage at the late phase (12 h; Figure 3d). Furthermore, Nlrp3 deficiency also prevented LPS+ATP-induced caspase-1 cleavage at 3 h (Figure 3e), as expected. In aggregate, these results indicate that Nlrp3 inflammasome is required for the HMGB1-induced early-phase activation of caspase-1, whereas HMGB1 endocytosis and subsequent CatB activation account for late-phase activation of caspase-1.

HMGB1 endocytosis induces pyroptosome formation

We next investigated more deeply the mechanism of the late-phase activation of caspase-1. It has been reported that the pyroptosome, a complex including adaptor protein apoptosis-associated speck-like protein containing a CARD (ASC), also known as ASC focus, recruits pro-caspase-1, resulting in its activation and proteolysis to the mature form via neighboring activated caspase-1 proteins.26 To determine whether the pyroptosome serves as machinery for HMGB1-induced late -phase caspase-1 activation, we visualized the ASC focus with florescence-tagged ASC antibody and confocal microscopy. At between 9 and 12 h after HMGB1 treatment, ASC foci were observed in WT BMMs (Figure 4a), but not in RAGE−/− BMMs or WT BMMs pre-treated with CatB inhibitor CA074me (Figures 4b and c).

Figure 4.

Figure 4

Open in a new tab

HMGB1-induced CatB activation and caspase-1 activation result in pyroptosome formation. (a and b) Confocal microscopy results of immunofluorescence of ASC foci in BMMs (original magnification × 600). WT BMMs were treated with HMGB1 (50 nmol/l) for 0–12 h, and ASC foci were stained to visualize pyroptosome formation (a). BMMs isolated from WT mice or RAGE−/− mice were stimulated with HMGB1 (50 nmol/l) for 12 h in the presence or absence of CA-074-me (10 μmol/l) (b). (c) Alterations in average number of ASC focus in BMMs, which were calculated using OLYMPUS Fluoview Ver.1.7c system. BMMs isolated from WT mice or RAGE−/− mice were stimulated with HMGB1 for 12 h in the presence or absence of CA-074-me followed by detection of ASC foci with florescence-tagged ASC antibody and confocal microscopy. The graph shows the mean and S.D., n=9. *P<0.05 versus all other groups. (d) BMMs isolated from WT mice or Nlrp3−/− mice were treated with HMGB1 (50 nmol/l) for 12 h or sequentially treated with LPS (3 h) plus ATP (1 h), and ASC (red) and Nlrp3 (green) were detected by immunofluorescence and confocal microscopy (original magnification × 600). (e) Mouse macrophage J774.2 cells were transfected with non-specific siRNA (Cont. siRNA) or ASC siRNA and stimulated with HMGB1 (50 nmol/l) for 0 or 12 h. Caspase-1 cleavage (10 kDa) in the cell lysates was detected by immunoblotting analysis. Images are representative of three independent experiments

As Nlrp3 is dispensable in the late-phase activation of caspase-1 as shown in Figures 3d and e, we next wanted to determine whether the pyroptosome, but not Nlrp3 inflammasome, accounts for the caspase-1 activation. We measured the physical interaction of ASC and Nlrp3 in BMMs in response to 12 h of treatment with HMGB1 or LPS plus ATP, a stimulation known to induce Nlrp3 inflammasome activation. As demonstrated in Figure 4d, LPS+ATP induced a co-localization of ASC and Nlrp3, suggesting an association of ASC and Nlrp3 in Nlrp3 inflammasome assembly. However, HMGB1-induced ASC foci were separate from Nlrp3, and Nlrp3 deletion failed to prevent the formation of ASC foci in response to HMGB1. There was no significant difference in the number of ASC foci between the cells of WT and Nlrp3−/−. These findings suggest that ASC has different roles in the pathways initiated by HMGB1 endocytosis and LPS+ATP.

To address ASC dependency of caspase-1 cleavage, we further knocked down ASC in J772.4 mouse macrophages using siRNA techniques. Knockdown of ASC in the cells significantly decreased HMGB1-induced caspase-1 cleavage at both 3 and 12 h (Figure 4e). Considered together with the results shown in Figure 3d, the effect of ASC on caspase-1 cleavage at 12 h is an Nlrp3 inflammasome-independent event.

HMGB1 endocytosis induces macrophage pyroptosis

Pyroptosis is a caspase-1-dependent programmed cell death.18 To determine whether pyroptosome formation and caspase-1 activation are followed by macrophage pyroptosis, we extended the observation time after the treatment of BMMs with HMGB1. At 18 h after HMGB1 stimulation, DNA fragmentation and caspase-1 activation, as detected by flow cytometry, occurred in the BMMs (Figure 5a), and morphologically, nuclear condensation (Figures 5c and d) and enlarged cell size plus caspase-1 activation (Figure 5d) were also observed using confocal microscopy. These cellular alterations are known characteristics of pyroptosis.27

Figure 5.

Figure 5

Open in a new tab

Endocytosis of HMGB1 induces macrophage pyroptosis. (a and b) BMMs were isolated from WT mice (a), caspase-1-deficient (casp-1−/−) mice, and Nlrp3-deficient (Nlrp3−/−) mice (b), and treated with HMGB1 (50 nmol/l) for 18 h. In some experiments, Z-YVAD-FMK (10 μmol/l) or CA-074-me (10 μmol/l) was added in the cell cultures (a). At the end of HMGB1 treatment, the BMMs were stained with Cell Death Reagent-TMR and Alexa Fluor 488-labeled caspase-1 FLICA, the double-stained pyroptotic cells were detected by flow cytometry. The rate of pyroptotic cell was calculated by the formula: (pyroptotic cells/total cells) × 100%. The graphs show the mean and S.D., n=3. *P<0.05 versus the group labeled with no asterisk. (c) BMMs isolated from WT, caspase-1−/−, or Nlrp3−/− mice were stimulated with HMGB1 for 18 h. In some experiments, CA-074-me was added into the cell culture. The BMMs were then stained with Cell Death Reagent (green) and Hoechst (blue), and fluorescent images were obtained by confocal microscopy (original magnification × 600). (d) Confocal microscopy of normal WT BMMs stained with cell mask membrane dye (red) and Hoechst (blue) to show the diameter of macrophage and nucleus (left). WT BMMs were stimulated with HMGB1 for 12 h, and then stained with Hoechst (blue) and FLICA caspase-1 fluorescent reagent (green), which indicates activated caspase-1 (right). Images are representative of three independent experiments (original magnification × 600). (e) Mouse macrophage J774.2 cells were transfected with non-specific siRNA (Cont. siRNA) or caspase-11 (Casp-11) siRNA and stimulated with HMGB1 (50 nmol/l) for 12 h. Caspase-11 cleavage (20 and 10 kDa) in the cell lysates was detected by immunoblotting analysis. (f) J774.2 cells that were transfected with non-specific siRNA (Cont. siRNA) or caspase-11 (Casp-11) siRNA were stimulated with HMGB1 for 18 h. At the end of HMGB1 treatment, the cells were stained with Cell Death Reagent-TMR and Alexa Fluor 488-labeled caspase-1 FLICA, the double-stained pyroptotic cells were detected by flow cytometry. The graphs show the mean and S.D., n=3. *P<0.05 versus the group labeled with no asterisk. (g) WT BMMs were stimulated with HMGB1 (50 nmol/L) or heated HMGB1 (100 °C, 5 min; 50 nmol/l) for 18 h. At the end of HMGB1 treatment, the cells were stained with Cell Death Reagent-TMR and Alexa Fluor 488-labeled caspase-1 FLICA, the double-stained pyroptotic cells were then detected by flow cytometry. The graphs show the mean and S.D., n=3. *P<0.05 versus the group labeled with no asterisk

To confirm the caspase-1 dependency of the observed pyroptosis, BMMs were treated with caspase-1 inhibitor Z-YVAD FMK 30 min before HMGB1 treatment. As shown in Figure 5a, caspase-1 inhibitor significantly suppressed HMGB1-induced cell death. This finding was further confirmed in the BMMs isolated from caspase-1 knockout mice and treated with HMGB1 (Figure 5b). Furthermore, suppression of CatB with its inhibitor CA074me prevented HMGB1-induced pyroptosis in the BMMs as well (Figure 5a). However, genetic deletion of Nlrp3 did not prevent BMM pyroptosis at 18 h after HMGB1 treatment in a significant way (Figures 5b and c). To further address if caspase-11, which may be inactive in caspase-1 genetic-deficient mice, is involved in the cell death mechanism, we knocked down caspase-11 in J772.4 mouse macrophages using siRNA techniques (Figure 5e). Knockdown of caspase-11 in the cells did not show an effect on the HMGB1-induced pyroptosis at 18 h (Figure 5f), although HMGB1 is able to induce caspase-11 activation (Figure 5e). In order to exclude a possible role of contaminated LPS in inducing the cell death, recombinant HMGB1 was heated at 100 °C for 5 min before adding to the BMMs. The heated HMGB1 failed to induce the cell death. Considered together, the HMGB1-induced macrophage pyroptosis is an Nlrp3 inflammasome-independent event.

To address whether the in vitro observation of HMGB1-RAGE signaling-mediated induction of macrophage pyroptosis also occurs in vivo, we detected the number of pyroptotic macrophage/monocytes in the lungs and peripheral blood of endotoxemia mice. High circulating HMGB1 level in endotoxemia mice has been reported previously.3 Endotoxemia induced AMs pyroptosis (Figure 6a) and blood monocytes pyroptosis (Figure 6b) at 18 h after LPS injection in WT mice. However, injection of neutralizing antibody against HMGB1 30 min before LPS markedly decreased monocyte pyroptosis in the blood following endotoxemia (Figure 6b). In contrast, endotoxemia failed to increase blood pyroptotic monocytes in RAGE−/− mice (Figure 6b). Taken together, the results suggest an in vivo role of the HMGB1-RAGE signaling in inducing macrophage/monocyte pyroptosis in endotoxemia.

Figure 6.

Figure 6

Open in a new tab

HMGB1 induces macrophage pyroptosis in mouse endotoxemia model. (a) C57BL/6 mice were injected with LPS (20 mg/kg BW) or normal saline (NS) intraperitoneally (i.p.). AMs were isolated at 18 h after LPS injection and stained with FLICA caspase-1 fluorescent reagent (green), Cell Death Reagent (red), and Hoechst (blue). Images were obtained by confocal microscopy (original magnification × 600). (b) WT or RAGE−/− mice were injected with LPS or NS i.p. Neutralizing anti-HMGB1 IgY (SHINO-TEST Corporation) or control nonimmune IgY (Fitzgerald, North Acton, MA) in a dose of 2 mg/kg BW was administered to some animals 30 min before LPS i.p. injection. Blood monocytes were collected at 18 h after LPS and stained with Cell Death reagent (TMR red) and FLICA caspase-1 fluorescent reagent (AF488), and double-stained pyroptotic monocytes were detected by flow cytometry. Results are representative of three independent experiments. The graph shows the mean and S.D., n=3. *P<0.05 versus the group labeled with no asterisk

Discussion

HMGB1 has a critical role at the intersection of the host inflammatory responses to both infectious and sterile threats. HMGB1 has been implicated as an endogenous proinflammatory mediator for inducing release of TNFα, IL-1β, and other proinflammatory cytokines, as well as mediating fever, anorexia, and the sickness syndrome in vivo.5 HMGB1 elicits cellular and biological inflammatory responses by signal transduction through several receptors that have been identified for their capacity to transduce activation signals from exogenous (TLR2, TLR4, and TLR9) and endogenous (RAGE) ligands.5 Previous studies established molecular mechanisms of HMGB1 binding and signaling through a TLR4-MyD88-NF-κB pathway that induces cytokine release and inflammation.5 However, the biological significance of the diversity of receptor signaling pathways initiated by HMGB1has not yet been fully elucidated. In the current study, we identified a novel RAGE-dependent signaling pathway, by which HMGB1 induces cell pyroptosis. We demonstrated that HMGB1 acting through RAGE on macrophages triggers dynamin-dependent endocytosis of HMGB1, which in turn initiates a cascade of cellular and molecular events, including CatB activation and release from ruptured lysosomes. This rupture is followed by pyroptosome formation and caspase-1 activation, which serves as a mechanism underlying the HMGB1-induced pyroptosis (Figure 7). These findings suggest a distinct HMGB1-initiated pathway that differs from those previously reported.

Figure 7.

Figure 7

Open in a new tab

Model of macrophage endocytosis of HMGB1 induces pyroptosis. HMGB1 acting through RAGE on macrophages triggers dynamin-dependent endocytosis of HMGB1, which in turn initiates a cascade of cellular and molecular events. These include CatB activation and release from ruptured lysosome followed by pyroptosome formation and caspase-1 activation, which serves as a mechanism underlying the HMGB1-induced pyroptosis

Endocytosis has important roles in many different areas of cell biology, ranging from the uptake of nutrients to regulation of intercellular signaling.28 Endocytic pathways have been mainly classified as clathrin-dependent or -independent,28 the later can be further classified as dynamin-dependent or –independent pathway. Dynamin is a large GTPase directly involved in pinching off endocytic vesicles from the plasma membrane.29, 30, 31 The dynamin activation in this study is secondary to RAGE activation, as genetic deletion of RAGE prevented HMGB1 endocytosis. Although RAGE was the first receptor implicated as a binding partner for HMGB1, the signaling detail of RAGE pathway is largely unknown.32, 33 Likewise, the linkage between RAGE and dynamin in the pathway is not clear yet and will be a future focus of the study. For many years, endocytosis of ligand molecules has been considered as a mechanism of signal attenuation via receptor and ligand clearance from the cell surface.34, 35 The current finding that the dynamin-dependent endocytosis of HMGB1 activates a cascade of intracellular events leading to cell pyroptosis, rather than diminishes the effect of HMGB1, represents a shift in our understanding of the significance of ligand endocytosis.

Lysosome rupture and lysosomal enzyme CatB release and activation were observed at 6 h after HMGB1 stimulation of the macrophages. The causal relationship between HMGB1 endocytosis and lysosome destabilization is supported by our data showing that prevention of HMGB1 endocytosis by genetic deletion of RAGE in macrophages, or applying dynamin inhibitor to WT macrophages blocked the induction of lysosome rupture. A recent study has shown that phagocytosis of silica crystal causes lysosome damage and leakage followed by CatB activation.20 Although the mechanism of crystal-induced lysosome damage has not been fully elucidated, a physical damaging effect of crystals on the lysosome is plausible. However, lysosome destabilization caused by HMGB1 protein translocating into the lysosome is a first-time observation, and implies a mechanism that involves a RAGE signaling-regulated molecular cascade. Understanding and fully defining this novel HMGB1-signaling pathway are important as this may lead to the identification of a common pathway for the induction of lysosome destabilization.

CatB has been suggested as an upstream activator of Nlrp3 inflammasome.20, 36 In the current study, however, we observed an induction of ASC foci formation, in the absence of Nlrp3 inflammasome activation, following CatB activation. The causal relationship between CatB activation and ASC foci formation is supported by our data that (i) CatB inhibitor suppresses HMGB1-induced ASC foci formation; (ii) HMGB1-induced ASC foci were geographically separated within the cell from Nlrp3; and (iii) Nlrp3 deficiency did not prevent the formation of ASC foci following HMGB1 stimulation. The mechanism by which CatB induces caspase-1-dependent cell pyroptosis is not clear, and will be further studied.

In this study, two distinct mechanisms of caspase-1 cleavage were identified after HMGB1 stimulation of macrophages. An early detectable caspase-1 cleavage was observed starting at 3 h after HMGB1 treatment, and this increased over time. The late HMGB1-induced caspase-1 cleavage at 12 h could be prevented by dynamin inhibition, CatB suppression, or RAGE genetic deletion, but was independent of Nlrp3, suggesting a pathway that depends on HMGB1 endocytosis. Whereas, caspase-1 cleavage at 3 h after HMGB1 treatment was an Nlrp3-dependent feature, which is similar to LPS+ATP-induced caspase-1 cleavage as shown in Figures 3d and e. Collectively, the data suggest that HMGB1 acting through different receptor signaling pathways sequentially induces differential cell responses.

We demonstrate in the current study that suppression of HMGB1 endocytosis or its downstream events, including inhibition of dynamin, CatB, and caspase-1 activation, prevent pyroptosis in macrophages. These findings support a causal role for HMGB1 endocytosis in induction of cell pyroptosis. Importantly, our in vitro finding was also confirmed in vivo in a model of mouse endotoxemia. The role of HMGB1 in inducing macrophage/monocyte pyroptosis in the endotoxemia model was evident by the fact that neutralizing antibody against HMGB1 significantly decreased monocyte pyroptosis in peripheral blood. Understanding the pathophysiological significance of HMGB1-induced macrophage/monocyte pyroptosis will be our next focus of study.

In summary, our study demonstrates a novel mechanism by which HMGB1 induces macrophage/monocyte pyroptosis through RAGE-mediated HMGB1 endocytosis. The finding sheds light on the regulatory role of ligand-receptor internalization in cell fate, which may have an important role in directing the progress of inflammation following infection and injury.

Materials and Methods

Mouse strains

All the mice used in the experiments were 9–10 weeks old and on a C57BL/6 background. WT C57BL/6 mice were purchased from the Jackson Laboratory (Bar Harbor, ME, USA). TLR4 knockout (TLR4−/−) mice, TLR2 knockout (TLR2−/−) mice, and RAGE knockout (RAGE−/−) mice were bred in Dr. Billiar's laboratory at the University of Pittsburgh; Caspase-1 knockout (caspase−1−/−) mice were originally provided by Dr. Richard Flavell (Yale University) and Nlrp3 knockout (Nlrp3−/−) mice were obtained from Millennium Pharmaceuticals (Cambridge, MA, USA). All the animal experimental protocols were reviewed and approved by the Institutional Animal Care and Use Committees of University of Pittsburgh and VA Pittsburgh Healthcare System.

Endotoxemia mouse model

Mice were given intraperitoneal injection (i.p.) of LPS (20 mg/kg BW). Neutralizing anti-HMGB1 IgY (SHINO-TEST Corporation, Kanagawa, Japan) or control nonimmune IgY (Fitzgerald, North Acton, MA, USA) in a dose of 2 mg/kg BW was administered to some animals 30 min before LPS i.p. At 18 h after LPS injection, the mice were anesthetized, and then a heart puncture was performed to collect blood samples to measure monocytes pyroptosis using two-color flow cytometry.

Expression vectors and recombinant proteins

The plasmid pGEX-4T-HMGB1 is a gift from Dr. Kimitoshi Kohno (University of Occupational and Environmental Health, Japan). His-tagged EGFP prokaryotic expression vector pET14b-His-EGFP was constructed with subcloning sites KpnI and XboI by a routine PCR strategy. The coding region of human HMGB1 was amplified by PCR cycles using pGEX-4T-HMGB1 as the template and a pair of specific primers (forward: 5′-CATGGTACCGGCAAAGGAGATCCTAAGAAGC-3′; reverse: 5′-CATGGTACCTTCATCATCATCATCTTCTTCTTCAT-3′). The PCR product was subcloned into pET14b-His-EGFP vector. The recombinant plasmids were proved by enzyme digestion and DNA sequencing. The plasmids were transformed into the Escherichia coli strain BL21(DE3, Invitrogen Life Technologies, Carlsbad, CA, USA) followed by induction with 1 mmol/l isopropyl β-D-thiogalactopyranoside. His-tagged fusion proteins were purified by using Ni-NTA purification system (Invitrogen Life Technologies) and followed by a resolution of 10% SDS-PAGE. In some experiments, the recombinant proteins HMGB1 and HMGB1-EGFP were heated at 100 °C for 5 min.

Cell isolation and culture

BMMs

Mice were euthanized and sprayed with 70% ethanol. The mouse femurs and tibias were used to prepare BMMs following a standard procedure.37 Bone marrow was flushed out with 5 ml BMM culture medium (DMEM containing 10% FBS complemented with 50 μg/ml penicillin/streptomycin and 10 ng/ml recombinant macrophage colony-stimulating factor (Sigma-Aldrich)). BM red blood cells were lysed, and resulting cells were resuspended with BMM culture medium at a concentration of 1 × 106 cells/ml and seeded into culture dishes. Fresh BMM medium was added at day 3 and changed once at day 5. BMMs were fully differentiated and ready for use at day 7.

AMs

AMs were isolated by bronchoalveolar lavage. The lavage fluid was centrifuged at 300 × g at 4 °C for 10 min, and the pelleted cells were resuspended and cultured in DMEM containing 10% FBS supplemented with 50 μg/ml penicillin/streptomycin. After incubation for 2 h, non-adherent cells were washed off with PBS, followed by medium refreshment.

J774.2 mouse macrophage cell line was purchased from Sigma-Aldrich.

Cell staining

Macrophages (5 × 104 cells) were seeded onto a 35-mm Petri dish and grew with DMEM containing 10% FBS for 12 h at 37 °C. After incubation in serum-free DMEM for 30 min, EGFP-tagged HMGB1 (HMGB1-EGFP) was added to the cells with a final concentration of 100 nmol/l. To identify the endocytosis pathways of HMGB1, different fluorophore-conjugated probes were used. Alexa Fluor 594 Transferrin Conjugate (10 μmol/l, Molecular Probes) together with HMGB1-EGFP was incubated with cells for the time as indicated at 37 °C. Lipid Raft Labeling kit (Molecular Probes) was also used to stain cells to identify lipid raft-dependent endocytosis following the manufacturer's instructions. To track the internalized protein in lysosome, LysoTracker Red (75 nmol/l; Molecular Probes) was used together with the fluorescent recombinant HMGB1 for up to 24 h at 37 °C. After incubation for up to 24 h, the cells were washed with PBS, followed by fixation with 4% paraformaldehyde (Sigma-Aldrich) and nuclear staining with 1 μg/ml Hoechst (Sigma-Aldrich) for 15 min. The cells were then observed by confocal microscopy (Olympus, Fluoview-FV1000, Olympus America Co., Center Valley, PA, USA).

Detection of lysosome rupture and CatB activation

Macrophages cultured in 35 mm Petri dishes were treated with HMGB1 (50 nmol/l) and DQ Ovalbumin (10 μg/ml, Molecular Probes) or Magic Red CatB assay reagent (10 μg/ml, Immunochemistry Technologies, Bloomington, MN, USA) at 37 °C for 1 h for detection of lysosome rupture and CatB activity. After fixation with 4% paraformaldehyde, the cells were visualized by confocal microscopy. Cells were randomly selected for the measurement of intracellular fluorescence intensity by using Olympus FV10-ASW software (Olympus).

Flow cytometry analysis of cell pyroptosis

Two-color flow cytometry was used to detect cell pyroptosis. BMMs, J722.4 cells, or mouse blood monocytes were incubated with Alexa Fluor 488-labeled caspase-1 FLICA at 37 °C for 1 h. After fixed with 4% paraformaldehyde, cells were stained with TMR red-labeled In-Situ Cell Death Detection reagent (Roche Applied Science, Indianapolis, IN, USA) following the manufacturer's instructions. The cells were then analyzed by flow cytometry. SSC and FSC were used to differentiate monocytes/macrophages. Background and auto-fluorescence were determined by a control antibody with the same isotype staining. Acquisition was performed on 10 000 events using a FACScalibur cytometer (BD Biosciences, San Jose, CA, USA) or BD LSR II (BD Biosciences) and CellQuestPro (BD Biosciences) and FlowJo-V10 software (Tree Star, Ashland, OR, USA). The double-stained cells were counted as pyroptotic cells, and the rate of pyroptotic cell was calculated by the formula: (pyroptotic cells/total cells) × 100%.

Western blot

BMM lysates were separated by 12% SDS-PAGE followed by transferring onto PVDF membranes. After blocking for 1 h at room temperature with blocking buffer (LI-COR Biosciences, Lincoln, NE, USA), blots were incubated with polyclonal antibody against mouse caspase-1 p10 antibody (sc-514, Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-caspase-11 antibody (ab22648, Abcam, Cambridge, MA, USA), or polyclonal anti-actin antibodies (sc-1615, Santa Cruz Biotechnology). The membranes were washed with PBS for three times and incubated with the appropriate secondary antibodies, respectively (LI-COR Biosciences). Protein bands were detected using Odyssey System from LI-COR Biosciences.

Immunofluorescence confocal microscopy

Macrophages were cytospun onto a microscopic slide and fixed with 4% paraformaldehyde for 20 min. After washing with PBS, the cells were permeabilized with 0.25% Triton X-100 in PBS for 10 min at room temperature, followed by blocking with 1% bovine serum albumin in PBST (PBS with 0.2% Tween-20) for 2 h at room temperature to reduce non-specific staining. The cells were then incubated with a primary antibody, including rabbit polyclonal anti-ASC Ab (sc-30153, Santa Cruz Biotechnology) or rabbit polyclonal anti-EEA1 Ab (Cell Signaling Technology, Beverly, MA, USA) at 4 °C overnight. After washing twice with PBS, the cells were incubated with Alexa Fluor 555-conjugated anti-rabbit IgG (Cell Signaling Technology) for 1 h at room temperature. Hoechst 33258 (Sigma-Aldrich) was used to stain nuclei. The cells were then washed with PBS for three times, followed by confocal microscopy.

Gene knockdown

J774.2 cells (4 × 105 cells) were cultured in 60-mm dishes for 24 h before transfection. 200 pmol per dish mouse ASC siRNA, caspase-11 siRNA, or non-specific siRNA (Santa Cruz Biotechnology) was transfected using Lipofectamine RNAiMAX Transfection Reagent (Invitrogen Life Technologies) following the manufacturer's instructions. At 48 h after transfection, the efficiency of the corresponding gene knockdown was confirmed with western blot.

Data presentation and statistical analysis

The data are presented as mean±S.D. of the indicated number of experiments. SPSS 13.0 (SPSS, Chicago, IL, USA) was used for statistical analysis. Significances between groups were determined by using one-way ANOVA or two-tailed Student's t-test and were considered statistically significant if the P value was less than 0.05.

Acknowledgments

This work was supported by the National Institutes of Health Grant R01-HL-079669 (JF and MAW), National Institutes of Health Center Grant P50-GM-53789 (TRB and JF), a VA Merit Award (JF), National Key Basic Research Program 2010CB529704 (YJ, China), PCSIRT IRT0731 (YJ), and National Natural Science Foundation of China 30670828 (YJ).

Author Contributions

JX, JW, XS, QL, YL, ZL, LF planned and did experiments including cell isolation and treatment, confocal microcopy, western blotting, and flow cytometry; JX, JW, XS did animal experiments and histological analysis; YJ, GX, SL, TRB, MAW, and JF planned the project and conceived the experiments; JX, YJ, LF, MJS, and JF conceived the data and wrote the manuscript.

Glossary

HMGB1

high-mobility group box 1

RAGE

receptor for advanced glycation end product

TLR

Toll-like receptor

CatB

cathepsin B

DAMPs

damage-associated molecular pattern

BMM

bone marrow-derived macrophages

AMs

alveolar macrophages

CT-B

cholera toxin-B

ASC

apoptosis-associated speck-like protein containing a CARD

The authors declare no conflict of interest.

Footnotes

Edited by RA Knight

References

  1. Mollen KP, Anand RJ, Tsung A, Prince JM, Levy RM, Billiar TR. Emerging paradigm: Toll-like receptor 4-sentinel for the detection of tissue damage. Shock. 2006;26:430–437. doi: 10.1097/01.shk.0000228797.41044.08. [DOI] [PubMed] [Google Scholar]
  2. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006;440:237–241. doi: 10.1038/nature04516. [DOI] [PubMed] [Google Scholar]
  3. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285:248–251. doi: 10.1126/science.285.5425.248. [DOI] [PubMed] [Google Scholar]
  4. Lu B, Nakamura T, Inouye K, Li J, Tang Y, Lundback P, et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature. 2012;488:670–674. doi: 10.1038/nature11290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol. 2011;29:139–162. doi: 10.1146/annurev-immunol-030409-101323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Wang H, Yang H, Czura CJ, Sama AE, Tracey KJ. HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med. 2001;164 (10 Pt 1:1768–1773. doi: 10.1164/ajrccm.164.10.2106117. [DOI] [PubMed] [Google Scholar]
  7. Yang H, Wang H, Czura CJ, Tracey KJ. The cytokine activity of HMGB1. J Leukoc Biol. 2005;78:1–8. doi: 10.1189/jlb.1104648. [DOI] [PubMed] [Google Scholar]
  8. Bucciarelli LG, Wendt T, Rong L, Lalla E, Hofmann MA, Goova MT, et al. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell Mol Life Sci. 2002;59:1117–1128. doi: 10.1007/s00018-002-8491-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. van Zoelen MA, van der Sluijs KF, Achouiti A, Florquin S, Braun-Pater JM, Yang H, et al. Receptor for advanced glycation end products is detrimental during influenza A virus pneumonia. Virology. 2009;391:265–273. doi: 10.1016/j.virol.2009.05.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. van Zoelen MA, Yang H, Florquin S, Meijers JC, Akira S, Arnold B, et al. Role of Toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock. 2009;31:280–284. doi: 10.1097/SHK.0b013e318186262d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell. 1999;97:889–901. doi: 10.1016/s0092-8674(00)80801-6. [DOI] [PubMed] [Google Scholar]
  12. Huttunen HJ, Kuja-Panula J, Sorci G, Agneletti AL, Donato R, Rauvala H. Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem. 2000;275:40096–40105. doi: 10.1074/jbc.M006993200. [DOI] [PubMed] [Google Scholar]
  13. Toure F, Zahm JM, Garnotel R, Lambert E, Bonnet N, Schmidt AM, et al. Receptor for advanced glycation end-products (RAGE) modulates neutrophil adhesion and migration on glycoxidated extracellular matrix. Biochem J. 2008;416:255–261. doi: 10.1042/BJ20080054. [DOI] [PubMed] [Google Scholar]
  14. Palumbo R, De Marchis F, Pusterla T, Conti A, Alessio M, Bianchi ME. Src family kinases are necessary for cell migration induced by extracellular HMGB1. J Leukoc Biol. 2009;86:617–623. doi: 10.1189/jlb.0908581. [DOI] [PubMed] [Google Scholar]
  15. Bassi R, Giussani P, Anelli V, Colleoni T, Pedrazzi M, Patrone M, et al. HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration. J Neuro-Oncol. 2008;87:23–33. doi: 10.1007/s11060-007-9488-y. [DOI] [PubMed] [Google Scholar]
  16. Kim JY, Park HK, Yoon JS, Kim SJ, Kim ES, Ahn KS, et al. Advanced glycation end product (AGE)-induced proliferation of HEL cells via receptor for AGE-related signal pathways. Int J Oncol. 2008;33:493–501. [PubMed] [Google Scholar]
  17. Hudson BI, Kalea AZ, Del Mar Arriero M, Harja E, Boulanger E, D'Agati V, et al. Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42. J Biol Chem. 2008;283:34457–34468. doi: 10.1074/jbc.M801465200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol. 2009;7:99–109. doi: 10.1038/nrmicro2070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Albert ML. Death-defying immunity: do apoptotic cells influence antigen processing and presentation. Nat Rev Immunol. 2004;4:223–231. doi: 10.1038/nri11308. [DOI] [PubMed] [Google Scholar]
  20. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008;9:847–856. doi: 10.1038/ni.1631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Jones LJ, Upson RH, Haugland RP, Panchuk-Voloshina N, Zhou M. Quenched BODIPY dye-labeled casein substrates for the assay of protease activity by direct fluorescence measurement. Anal Biochem. 1997;251:144–152. doi: 10.1006/abio.1997.2259. [DOI] [PubMed] [Google Scholar]
  22. Santambrogio L, Sato AK. Carven GJ, Belyanskaya SL, Strominger JL, Stern LJ. Extracellular antigen processing and presentation by immature dendritic cells. Proc Natl Acad Sci USA. 1999;96:15056–15061. doi: 10.1073/pnas.96.26.15056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem. 1999;68:383–424. doi: 10.1146/annurev.biochem.68.1.383. [DOI] [PubMed] [Google Scholar]
  24. Xiang M, Shi X, Li Y, Xu J, Yin L, Xiao G, et al. Hemorrhagic shock activation of NLRP3 inflammasome in lung endothelial cells. J Immunol. 2011;187:4809–4817. doi: 10.4049/jimmunol.1102093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Xu P, Wen Z, Shi X, Li Y, Fan L, Xiang M, et al. Hemorrhagic shock augments Nlrp3 inflammasome activation in the lung through impaired pyrin induction. J Immunol. 2013;190:5247–5255. doi: 10.4049/jimmunol.1203182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Stehlik C, Lee SH, Dorfleutner A, Stassinopoulos A, Sagara J, Reed JC. Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation. J Immunol. 2003;171:6154–6163. doi: 10.4049/jimmunol.171.11.6154. [DOI] [PubMed] [Google Scholar]
  27. Miao EA, Rajan JV, Aderem A. Caspase-1-induced pyroptotic cell death. Immunol Rev. 2011;243:206–214. doi: 10.1111/j.1600-065X.2011.01044.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Hansen CG, Nichols BJ. Molecular mechanisms of clathrin-independent endocytosis. J Cell Sci. 2009;122 (Pt 11:1713–1721. doi: 10.1242/jcs.033951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Bashkirov PV, Akimov SA, Evseev AI, Schmid SL, Zimmerberg J, Frolov VA. GTPase cycle of dynamin is coupled to membrane squeeze and release, leading to spontaneous fission. Cell. 2008;135:1276–1286. doi: 10.1016/j.cell.2008.11.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Pucadyil TJ, Schmid SL. Real-time visualization of dynamin-catalyzed membrane fission and vesicle release. Cell. 2008;135:1263–1275. doi: 10.1016/j.cell.2008.11.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Roux A, Antonny B. The long and short of membrane fission. Cell. 2008;135:1163–1165. doi: 10.1016/j.cell.2008.12.003. [DOI] [PubMed] [Google Scholar]
  32. Hori O, Brett J, Slattery T, Cao R, Zhang J, Chen JX, et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem. 1995;270:25752–25761. doi: 10.1074/jbc.270.43.25752. [DOI] [PubMed] [Google Scholar]
  33. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest. 1995;96:1395–1403. doi: 10.1172/JCI118175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. NatCcell Biol. 2003;5:410–421. doi: 10.1038/ncb975. [DOI] [PubMed] [Google Scholar]
  35. Sigismund S, Argenzio E, Tosoni D, Cavallaro E, Polo S, Di Fiore PP. Clathrin-mediated internalization is essential for sustained EGFR signaling but dispensable for degradation. Dev Cell. 2008;15:209–219. doi: 10.1016/j.devcel.2008.06.012. [DOI] [PubMed] [Google Scholar]
  36. Zitvogel L, Kepp O, Kroemer G. Decoding cell death signals in inflammation and immunity. Cell. 2010;140:798–804. doi: 10.1016/j.cell.2010.02.015. [DOI] [PubMed] [Google Scholar]
  37. Weischenfeldt J, Porse B. Bone marrow-derived macrophages (BMM): isolation and applications. CSH Protoc. 2008;2008:pdb prot5080. doi: 10.1101/pdb.prot5080. [DOI] [PubMed] [Google Scholar]

Articles from Cell Death and Differentiation are provided here courtesy of Nature Publishing Group

RESOURCES